Recruiting Kidney Cancer Studies in Columbus
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
This is a phase 3, open label, single arm study of padeliporfin in the treatment of Upper Tract Urothelial Carcinoma (UTUC). The ENLIGHTED study will recruit patients with low-grade non-invasive upper...
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
The purpose of this study is to determine if the use of immunotherapy nivolumab and the targeted therapy cabozantinib prior to removal of the kidney, will increase the number subjects who are without ...
About Kidney Cancer Clinical Trials in Columbus
Kidney cancer, most commonly renal cell carcinoma, develops in the lining of the kidney tubules. It accounts for about 3-5% of all adult cancers. Treatment includes surgery, targeted therapy, immunotherapy, and radiation.
There are currently 2 kidney cancer clinical trials recruiting participants in Columbus, OHIO. These studies are seeking a combined 148 participants. Research is being sponsored by Steba Biotech S.A., Mark Stein. Clinical trial participation is free and participants receive study-related medical care at no cost.
Kidney Cancer Clinical Trials in Columbus — FAQ
Are there kidney cancer clinical trials in Columbus?
Yes, there are 2 kidney cancer clinical trials currently recruiting in Columbus, OHIO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbus?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.
Are clinical trials in Columbus free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.
What kidney cancer treatments are being tested?
The 2 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for kidney cancer.
Data updated March 2, 2026 from ClinicalTrials.gov